Cargando…
Safety and Efficacy of Telavancin at an Outpatient Parenteral Antibiotic Therapy (OPAT) Unit in New York City
BACKGROUND: Telavancin is an intravenous (IV) lipoglycopeptide with concentration-dependent bactericidal activity against a broad spectrum of gram-positive organisms and is approved for the treatment of skin and skin structure infections and nosocomial pneumonia; however, post-marketing data is limi...
Autores principales: | Rodriguez, George D, Polo, Lorena, Urban, Carl, Turett, Glenn, Prasad, Nishant, Warren, Nathan, Tsapepas, Demetra, Ghimire, Rabindra, Segal-Maurer, Sorana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631385/ http://dx.doi.org/10.1093/ofid/ofx163.801 |
Ejemplares similares
-
Implementation of a Collaborated Antimicrobial Stewardship Program and Outpatient Parenteral Antimicrobial Therapy (OPAT) Unit-driven Monoclonal Antibody Therapy Program for COVID-19 at an NYC Hospital
por: Rodriguez, George D., et al.
Publicado: (2022) -
OPAT: outpatient parenteral antimicrobial therapy
Publicado: (2020) -
Streptococcus pseudoporcinus: Case Reports and Review of the Literature
por: Khan, Shanza, et al.
Publicado: (2020) -
Outpatient parenteral antibiotic therapy (OPAT) for the management of bronchiectasis
por: Tu, Jacky, et al.
Publicado: (2023) -
Outpatient parenteral antimicrobial therapy (OPAT) in patients with cystic fibrosis
por: Pedersen, Maya Graham, et al.
Publicado: (2015)